Skip to main content
Premium Trial:

Request an Annual Quote

NRGene Completes $30.6M IPO

NEW YORK – NRGene said Tuesday that it has completed its initial public offering on the Tel Aviv Stock Exchange, raising approximately NIS 100 million ($30.6 million). The IPO values the Israeli company at NIS 370 million.

Herzog Fox & Neeman and PwC Israel advised the company on the IPO.

NRGene, based in Ness Ziona, Israel, develops artificial intelligence technologies to analyze agricultural and livestock genomic data. Products include DeNovoMax software for assembling reference-level genomes for use in breeding and agriculture.

"Going public is a significant milestone in the company's plan for growth," NRGene Chairman Asaf Levi said in a statement. He said that the firm would apply the new funding to support growth and form long-term collaborations with breeding companies.

"The company currently plans to expand its global activities and become an integral part of the optimization processes in agriculture and the food industry," added CEO and Cofounder Gil Ronen. "We estimate that in the near future NRGene will become a key player in this highly important and growing field."

Existing customers include Bayer and Syngenta, according to NRGene. The firm adopted a new business model last year that involves joint development of intellectual property in return for royalties from sales of associated products. 

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.